Evidence map›Paper›PMID 36655214›Full record

ArticlePhysics and imaging in radiation oncology2023

Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time.

Nicholas Hardcastle, Mathieu Gaudreault, Adam U Yeo, Elena Ungureanu, Cathy Markham, Rebecca Barnes, Sarat Chander, Julie Chu

Open access · goldAbstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nicholas HardcastlePhysical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Mathieu GaudreaultPhysical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Adam U YeoPhysical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Elena UngureanuPhysical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Cathy MarkhamDepartment of Radiation Therapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Rebecca BarnesDepartment of Radiation Therapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Sarat ChanderSir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
Julie ChuPhysical Sciences, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Peter MacCallum Cancer Centre · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Reduction of respiratory tumour motion is important in liver stereotactic body radiation therapy (SBRT) to reduce side effects and improve tumour control probability. We have assessed the distribution of use of voluntary exhale breath hold (EBH), abdominal compression (AC), free breathing gating (gating) and free breathing (FB), and the impact of these on treatment time. Materials and Methods: We assessed all patients treated in a single institution with liver SBRT between September 2017 and September 2021. Data from pre-simulation motion management assessment using fluoroscopic assessment of liver dome position in repeat breath holds, and motion with and without AC, was reviewed to determine liver dome position consistency in EBH and the impact of AC on motion. Treatment time was assessed for all fractions as time from first image acquisition to last treatment beam off. Results: Of 136 patients treated with 145 courses of liver SBRT, 68 % were treated in EBH, 20 % with AC, 7 % in gating and 5 % in FB. AC resulted in motion reduction < 1 mm in 9/26 patients assessed. Median treatment time was higher using EBH (39 min) or gating (42 min) compared with AC (30 min) or FB (24 min) treatments. Conclusions: Motion management in liver SBRT needs to be assessed per-patient to ensure appropriate techniques are applied. Motion management significantly impacts treatment time therefore patient comfort must also be taken into account when selecting the technique for each patient.

Indexed as

Abdominal compressionAC, Abdominal CompressionBED, Biologically Effective DoseCBCT, Cone Beam Computed TomographyEBH, Exhale Breath Holdexhale breath hold. Stereotactic ablative body radiotherapyFB, Free BreathingFFF, Flattening Filter FreeGTV, Gross Tumor VolumeIMRT, Intensity Modulated Radiation TherapyITV, Internal Target VolumeLiverMotion managementPTV, Planning Target VolumeSBRT, Stereotactic body radiation thearpyStereotactic body radiation therapyVMAT, Volumetric Modulated Arc Therapy

Identifiers

PMID36655214
PMCPMC9841271
OpenAlexW4313529564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.